influenza vaccine target highly variable surface glycoprotein hemagglutinin neuraminidas caps inconveni vaccine every year reason develop universe target conserve viral common need studi genre recombin adenoviru rad vaccine encode nucleoprotein np april virus design rank basic mouse immune entrants siblings subset challenge lethal dose heterolog well homolog virus found entrants immune elicit strong mucosa iga response stronger cd cell toward immunodomin restrict editor siblings importantly single provide potent protect challenge result suggest could candid administer 